Analyst Report: SKYD
1. EXECUTIVE SUMMARY
Skydance fell 24.56% over the week to a $6.91 close on Friday 16 October, from $9.16 on 9 October, and a single session produced almost all of it: on 14 October the shares dropped 23.84% to $7.06 as roughly 471 million warrants began trading separately under SKYD.WS (Deadline, Yahoo Finance). The sources tie the fall to that distribution and to the valuation reset that followed, but the size of the drop is larger than the exchange's own reference-price adjustment, and the research does not explain the gap. The shares added 2.83% on 15 October and lost 4.82% on 16 October, with only headlines available as explanation for either move. Morningstar cut fair value to $12 from $15, the stock sits at its lowest close of the past ten sessions, and the next scheduled test is earnings on 9 November.
2. THE CATALYST
The event broke on Wednesday 14 October, the ex-distribution date. About 471 million warrants, one per Class B share held at the 5 October record date, went to holders of roughly 9% of the stock (Deadline; company announcement feed). Each warrant allows the holder to buy one Class B share at $12 and runs to October 2036, with earlier expiry possible under certain conditions (Fox Business). The warrants closed their first session at $2.20 on the NYSE (Deadline).
On the same day the shares closed at $7.06, down 23.84% from $9.27, on volume of 92,470,100, about 4.1 times the 50-session average of 22,635,868. Benzinga reported the stock was down as much as 25% before the company issued a clarification and then recovered a little. Deadline reported that about 90% of the investor base, including Larry Ellison and RedBird Capital, did not receive warrants.
The $2.21 fall in the share price is close to the warrants' $2.20 closing value. The NYSE, however, cut the stock's reference price by only $0.19368, to about $9.07 (BigGo Finance). One inference is that the exchange adjustment scales with the roughly 9% of holders who received warrants, since $0.19368 is close to 9% of $2.20. That would leave the remainder of the fall to selling by the 90% who received nothing, but no source in the research confirms this, and the NYSE notice has not been checked.
| Session | Close | Change | Volume | Sourced driver |
|---|---|---|---|---|
| 2026-10-07 | $8.89 | -6.72% | 43,300,200 | None found (merger closed 6 October per Fox Business) |
| 2026-10-14 | $7.06 | -23.84% | 92,470,100 | Warrants trade separately |
| 2026-10-15 | $7.26 | +2.83% | 52,583,600 | Headline only: warrant selloff fading (Yahoo Finance) |
| 2026-10-16 | $6.91 | -4.82% | 35,721,900 | Headline only: financial concerns (Yahoo Finance) |
3. COMPANY PROFILE
Skydance Corporation is a media and entertainment company in the Communication Services sector, reporting in three segments: Studios, Direct-to-Consumer and TV Media. Its assets include the CBS Television Network and CBS Stations, international free-to-air networks such as Network 10 and Channel 5, and cable brands including Nickelodeon, MTV, Comedy Central and BET, along with Paramount+ with SHOWTIME. Listed peers in Movies & Entertainment include Netflix, Disney, Live Nation and TKO. The market capitalisation is $34.84bn, the forward P/E is 34.8 and the dividend yield is 2.75%.
Fox Business reports that Skydance completed its takeover of Warner Bros. Discovery on 6 October. BigGo Finance cites pro forma net debt of about $78.9bn and a management target of $6bn in annual synergies within three years. Morningstar calls the deal dilutive and says the debt carries substantial risk. One report cited by StockTwits says the Ellison family bought about 1.4 billion shares at $12 as part of the deal financing; this rests on a single source. The next earnings report on 9 November carries estimates of $0.18 EPS and $7.02bn revenue.
4. DEEP DIVE ANALYSIS
Do fundamentals justify the move? The warrant event changes the share structure and the sentiment around it, and the sourced fundamentals changed little that day. Morningstar's analyst Matthew Dolgin cut fair value to $12 from $15 after the warrants began trading separately. The $3 cut is smaller than the $2.21 price fall plus the prior discount, and the $12 fair value still sits well above the $6.91 close. Bernstein SocGen cut its target to $6.00 from $12.00 and kept Underperform, although the source gives no date. BigGo Finance lists Barclays at $7 and StoneX at $11, again from a single undated source. TipRanks shows a Hold consensus with an average target of $10.21, which is 47.8% above the close. Simply Wall St's model fair value moved to US$9.42 from US$9.81, which is a model estimate and not a broker target.
Peer and sector read-across. Peers did not follow the stock. Over the same period Netflix rose 0.33%, Disney 2.35%, Live Nation 0.11% and TKO fell 1.41%, while the S&P 500 lost 1.95%. 24/7 Wall St. reported that Netflix and Disney edged up on 14 October and the communication services ETF was flat. Netflix's staff cut and executive hire are company-specific. SKYD therefore trailed the index by about 22.6 percentage points over the week, and the drop belongs to the stock itself.
Comparable episodes. Variety's headline puts the first trading day after the merger close at a 2.7% decline. The 7 October fall of 6.72% on volume of 43,300,200 has no sourced cause, and the 8 October rebound of 4.39% came on 55,631,100 shares. Both sessions point to heavy turnover around the deal close.
Bull case. The warrant distribution does not alter operations, and Morningstar's $12 fair value and the $10.21 consensus target sit far above the price. The synergy target of $6bn a year, if delivered, addresses the debt load over three years. Selling pressure showed signs of fading on 15 October.
Bear case. Net debt near $78.9bn leaves little room for error, and Morningstar calls the deal dilutive. The 90% of holders who received no warrants carry the full price reset. The company can bring the warrant deadline forward when the stock stays above $30 for a set period (StockTwits), which keeps a large block of potential new shares outstanding for a decade. The 16 October headline from Yahoo Finance points to financial concerns, though the article was not read. The stock closed below the 14 October close on the latest session, and Bernstein's $6.00 target sits 13.2% below the latest close.
5. TECHNICAL SNAPSHOT
The $6.91 close is the lowest in the ten-session table and sits below both the 50-day average of $9.95 and the 200-day average of $10.23. The 52-week range runs from $17.11 on 16 October 2025 to $6.63 on 14 October 2026, and the stock trades 59.6% below the high and 4.2% above the low, with the latest session's intraday low of $6.80 holding above the 14 October extreme. Because the close is the table's lowest, no support level can be named from the closes; the 52-week low of $6.63 is the nearest reference. Nearest resistance is $7.06, the 14 October close. Volume on 16 October was 35,721,900, or 1.58 times the 50-session average, so participation stayed elevated three sessions after the 92,470,100 peak.
6. RISK FACTORS
- Unexplained gap: the share price fell $2.21 against an exchange adjustment of $0.19368, and no source reconciles the two. The NYSE notice is unchecked.
- Debt: pro forma net debt of about $78.9bn, with the "financial concerns" headline of 16 October unread.
- Index selling: a Barron's headline from 12 October warned that index selling could hurt the price; the article was not opened.
- Warrant overhang: 471 million warrants at $12 stay outstanding to October 2036.
- Source quality: the Bernstein, Barclays and StoneX actions lack dates, and the Morningstar cut is dated 14 October in its own report but 15 October by StockTwits.
- Macro: the S&P 500 fell 1.09% on 16 October.
Dated catalysts: third-quarter earnings on 9 November 2026 (EPS estimate $0.18, revenue estimate $7.02bn).
7. ACTIONABLE OUTLOOK
Short term (1-2 weeks): the stock trades at its lowest close in the table with elevated volume, and the close sits 4.2% above the 52-week low of $6.63. A close above $7.06 would show buyers absorbing the warrant-driven selling; a break below $6.63 would open a new low. The unread 16 October headline leaves the cause of the latest decline unknown.
Medium term (1-3 months): the 9 November earnings report is the first chance to see the combined company's results, leverage and synergy progress. Targets range from $6.00 at Bernstein to $12 at Morningstar, so the debate is wide, and the consensus Hold sits at $10.21.
Long-term thesis: the sourced evidence shows no change in the business plan, and Morningstar's fair value cut of $3 reflects the warrant adjustment. The thesis rests on delivering $6bn of synergies against $78.9bn of net debt. This is analysis only and not personal financial advice.